58559-52-7

Basic information

• Product Name: ethyl 2-(3-aminophenoxy)acetate
• Synonyms: ethyl 2-(3-aminophenoxy)acetate
• CAS NO: 58559-52-7
• Molecular Weight: 195.218
• Mol File: 58559-52-7.mol
• Article Data: 12

Chemical Properties

• CAS DataBase Reference: ethyl 2-(3-aminophenoxy)acetate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl 2-(3-aminophenoxy)acetate(58559-52-7)
• EPA Substance Registry System: ethyl 2-(3-aminophenoxy)acetate(58559-52-7)

Safety Data

• Hazardous Substances Data: 58559-52-7(Hazardous Substances Data)

Upstream product

• 591-27-5 m-Hydroxyaniline 
• 5544-77-4 2-(3-nitrophenoxy)-acetic acid ethyl ester 
• 7439-89-6 iron 
• 1878-88-2 2-(3-nitrophenoxy)acetic acid 
• 554-84-7 meta-nitrophenol 
• 19962-06-2 tert-butyl 3-hydroxyphenylcarbamate 
• 170856-29-8 Ethyl 3-(N-tert-butyloxycarbonylamino)phenyloxyacetate 
• 6274-24-4 (3-amino-phenoxy)-acetic acid 
• 64-17-5 ethanol 

Downstream Products

• 62877-06-9 (3-aminophenoxy)acetamide 
• 170855-82-0 1,5-Bis-(cyclopropylcarbonylmethyl)-3-(N'-(m-(carboethoxymethoxy)phenyl)ureido)-1H-1,5-benzodiazepine-2,4(3H,5H)-dione 
• 1202760-25-5 C₂₅H₃₀FN₅O₄ 
• 1202757-27-4 N-(3-(5-fluoro-2-(3-(2-hydroxy-2-methylpropoxy)phenylamino)pyrimidin-4-ylamino)phenyl)acrylamide 
• 1202760-26-6 C₂₀H₂₂FN₅O₂ 
• 1610767-43-5 C₁₈H₁₅N₅O₄ 
• 1610767-41-3 isopropyl 2-[3-[[(E)-N'-cyano-N-(4-cyano-3-methoxyphenyl)carbamimidoyl]amino]phenoxy]acetate 
• 1610767-33-3 C₂₀H₂₁N₃O₄S 
• 1610767-26-4 C₁₉H₁₉N₃O₄S 
• 1310744-77-4 (R)-2-(3-(((3-(carboxymethoxy)phenyl)amino)methyl)benzamido)pentanedioic acid 
• 1257341-94-8 5,7-dichloro-4-[(3-ethoxycarbonylmethoxyphenylcarbamoyl)-methoxy]-naphthalene-2-carboxylic acid methyl ester 
• 1202760-24-4 C₂₅H₂₈FN₅O₅ 
• 50963-77-4 3-(2-hydroxyethoxy)aniline 
• 1093799-15-5 C₂₆H₃₄N₆O₆ 

Relevant articles and documents

KIF18A INHIBITORS

Amide compounds of formula (I): and compositions containing them, and processes for preparing such compounds. Provided herein also are methods of treating disorders or diseases treatable by inhibition of Kinesin Motor Protein KIF18A, such as cancer, psoriasis, atopic dermatitis, an autoimmune disorder, or inflammatory bowel disease, and the like.

AZAQUINAZOLINE INHIBITORS OF ATYPICAL PROTEIN KINASE C

The present invention provides a compound of formula (I) or a salt thereof, wherein R7, R8, R9, G, and X are as defined herein. A compound of formula (I) and its salts have a PKC inhibitory activity, and may be used to treat proliferative disorders.

HETEROARYL COMPOUNDS AND USES THEREOF

The present invention provides inhibitors of protein kinases of formula I-a and I-b, pharmaceutically acceptable compositions thereof, and methods of using the same.